Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -3985.58% is 119% below its 5-year average of -1821.58%, near the low end of its 5-year range (-14359.92%–36100.17%).
81.54% below its 12-month average of -2195.37%.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-05-31): 0.00%.
NET PROFIT MARGIN
-3985.58%
NET PROFIT MARGIN AVG TTM
-2195.37%
NET PROFIT MARGIN AVG 3Y
-1432.52%
NET PROFIT MARGIN AVG 5Y
-1821.58%
NET PROFIT MARGIN AVG 10Y
-2477.07%
NET PROFIT MARGIN AVG 15Y
-1946.54%
NET PROFIT MARGIN AVG 20Y
-1190.22%
CURRENT VS TTM AVG
-81.54%
CURRENT VS 3Y AVG
-178.22%
CURRENT VS 5Y AVG
-118.80%
CURRENT VS 10Y AVG
-60.90%
CURRENT VS 15Y AVG
-104.75%
CURRENT VS 20Y AVG
-234.86%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 701 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Lexaria Bioscience Corp.
Market Cap
$4.79M
Net Profit Margin
-3985.58%
TTM Avg
-2195.37%
3Y Avg
-1432.52%
5Y Avg
-1821.58%
Market Cap
$4.72M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.69M
Net Profit Margin
-118.27%
TTM Avg
-13237.88%
3Y Avg
-7961.50%
5Y Avg
-5307.67%
Market Cap
$4.50M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.14M
Net Profit Margin
-4011.86%
TTM Avg
-2005.93%
3Y Avg
-2671.67%
5Y Avg
-1781.12%
Market Cap
$5.17M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.19M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1794.91%
5Y Avg
-2605.04%
Market Cap
$4.40M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.20M
Net Profit Margin
-106.78%
TTM Avg
-43.08%
3Y Avg
-12.30%
5Y Avg
-12.30%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $4.79M | -3985.58% | -2195.37% | -1432.52% | -1821.58% |
| CalciMedica, Inc. (CALC)vs › | $4.72M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.69M | -118.27% | -13237.88% | -7961.50% | -5307.67% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.14M | -4011.86% | -2005.93% | -2671.67% | -1781.12% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| Imunon, Inc. (IMNN)vs › | $5.19M | 0.00% | 0.00% | -1794.91% | -2605.04% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.20M | -106.78% | -43.08% | -12.30% | -12.30% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | -612568.11% | 0.00% | 0.00% | 0.00% |
Operating Margin
-1683.0%
Net Profit Margin
-3985.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-05-31 | 0.00% |
| 2026-02-28 | -7249.89% |
| 2025-11-30 | 0.00% |
| 2025-08-31 | -1549.33% |
| 2025-05-31 | -2177.64% |
| 2025-02-28 | -1559.32% |
| 2024-11-30 | -1470.02% |
| 2024-08-31 | -2600.94% |
| 2024-05-31 | -2121.06% |
| 2024-02-29 | -447.96% |
| 2023-11-30 | -779.57% |
| 2023-08-31 | 36100.17% |
| 2023-05-31 | -3051.86% |
| 2023-02-28 | -6482.55% |
| 2022-11-30 | -1796.64% |
| 2022-08-31 | -1320.26% |
| 2022-05-31 | -2389.69% |
| 2022-02-28 | -4651.80% |
| 2021-11-30 | -14359.92% |
| 2021-08-31 | -3797.72% |
| 2021-05-31 | -1253.09% |
| 2021-02-28 | 210.47% |
| 2020-11-30 | -235.42% |
| 2020-08-31 | -534.59% |
| 2020-05-31 | -3737.70% |
| 2020-02-29 | -2530.94% |
| 2019-11-30 | -8781.57% |
| 2019-08-31 | -861.76% |
| 2019-05-31 | -1955.26% |
| 2019-02-28 | -7479.16% |
| 2018-11-30 | -3158.14% |
| 2018-08-31 | -1262.88% |
| 2018-05-31 | -2440.44% |
| 2018-02-28 | -801.58% |
| 2017-11-30 | -2349.15% |
| 2017-08-31 | -5469.54% |
| 2017-05-31 | -1159.30% |
| 2017-02-28 | -3553.26% |
| 2016-11-30 | -4286.67% |
| 2016-08-31 | -3672.42% |
| 2016-05-31 | -4151.70% |
| 2016-02-29 | -1714.68% |
| 2015-11-30 | -3545.64% |
| 2015-08-31 | -11136.23% |
| 2015-05-31 | -6504.88% |
| 2015-02-28 | -15907.32% |
| 2014-11-30 | 0.00% |
| 2014-07-31 | -418.03% |
| 2014-04-30 | -293.94% |
| 2014-01-31 | -63.64% |
| 2013-10-31 | -52.37% |
| 2013-07-31 | -22.93% |
| 2013-04-30 | -18.76% |
| 2013-01-31 | -31.89% |
| 2012-10-31 | 6.70% |
| 2012-07-31 | 13.78% |
| 2012-04-30 | -160.24% |
| 2012-01-31 | -47.69% |
| 2011-10-31 | 0.54% |
| 2011-07-31 | -77.20% |
| 2011-04-30 | -54.16% |
| 2011-01-31 | -49.68% |
| 2010-10-31 | -58.61% |
| 2010-07-31 | -24.02% |
| 2010-04-30 | -403.01% |
| 2010-01-31 | -421.51% |
| 2009-10-31 | -176.24% |
| 2009-07-31 | -160.79% |
| 2009-04-30 | -317.50% |
| 2009-01-31 | -126.00% |
| 2008-10-31 | -328.39% |
| 2008-07-31 | -25.45% |
| 2008-04-30 | -246.46% |
| 2008-01-31 | -18.58% |
| 2007-10-31 | 677.90% |
| 2007-07-31 | -1294.95% |
| 2007-04-30 | -937.14% |
| 2007-01-31 | -1197.98% |
| 2006-10-31 | 0.00% |
| 2006-07-31 | 0.00% |
| 2006-04-30 | 0.00% |
| 2006-01-31 | 0.00% |
